Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Shares of Genetron Holdings Ltd. (GTH) are rising over 24%, after the company announced an exclusive strategic partnership agreement with Chia Tai Tianqing Pharmaceutical Group Co. Ltd., a subsidiary of Sino Biopharmaceutical Ltd., for HCCscreen, Genetron Health's blood-based early screening test for hepatocellular carcinoma or HCC in China.


RTTNews | Jan 6, 2021 10:07AM EST

10:07 Wednesday, January 6, 2021 (RTTNews.com) - Shares of Genetron Holdings Ltd. (GTH) are rising over 24%, after the company announced an exclusive strategic partnership agreement with Chia Tai Tianqing Pharmaceutical Group Co. Ltd., a subsidiary of Sino Biopharmaceutical Ltd., for HCCscreen, Genetron Health's blood-based early screening test for hepatocellular carcinoma or HCC in China.

As per the deal, the companies would work together exclusively to co-market and co-promote HCCscreen in the hospital market, covering designated territories in China.

The stock has been trading in the range of $9.03 - $17.71 for the past one year, and is currently trading at $17.10, up $3.39 or 24.72%, with trading volume of 483K versus an average volume of 316K shares.

Read the original article on RTTNews ( https://www.rttnews.com/3158202/stock-alert-genetron-holdings-shares-surge-24.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC